Clinical characteristics of dermatologic manifestations of COVID‐19 infection
Skin rashes have been frequently described in patients with COVID-19. This article co-authored by Cromos Pharma CEO Dr Vlad Bogin and published in the International Journal of Dermatology (3 July 2020) examines the dermatologic manifestations of COVID-19. It includes a case series of 15 patients, review of literature, and proposed etiological classification. Read the full article here
Clinical Trials Market Size, Share & Trends Analysis Report: Research and Markets
Research and Markets added “Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Observational, Expanded Access), by Indication and Segment Forecasts, 2020 – 2027″ to its reports yesterday (28 July 2020). Key findings from the report: The global clinical trials market size is
FDA proposes new rule on reporting requirements to support Right to Try
On July 23, the U.S. Food and Drug Administration (FDA) announced a new proposed rule that would require sponsors and manufacturers who provide an ‘‘eligible investigational drug’’ under the Right to Try Act to submit an annual summary of such use to FDA. The Right to Try Act (RTT), or the Trickett Wendler, Frank Mongiello,
